Mysulin R Injection 40 IU/ml contains Insulin Human [rDNA], a recombinant DNA-derived short-acting insulin designed to regulate blood glucose levels in patients with diabetes mellitus. As a rapid-acting insulin, it effectively lowers blood sugar during meals and is commonly used to manage postprandial hyperglycemia in both type 1 and type 2 diabetic patients.

Insulin Human [rDNA] is produced using recombinant DNA technology, providing a high-purity, consistent, and reliable alternative to animal-derived insulin. This insulin mimics the action of naturally occurring human insulin, promoting glucose uptake by tissues, reducing hepatic glucose production, and maintaining overall blood glucose homeostasis. Mysulin R Injection 40 IU/ml is formulated for precise and predictable action, ensuring optimal glycemic control when used under proper medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Mysulin R Injection 40 IU/ml is indicated for:

• Type 1 diabetes mellitus – to manage fasting and postprandial blood glucose levels as part of multiple daily injection regimens or insulin pump therapy

• Type 2 diabetes mellitus – when oral antidiabetic medications alone are insufficient for glycemic control

• Control of hyperglycemia during illness, surgery, or stress in diabetic patients

• Temporary management of elevated blood glucose in hospitalized patients or acute conditions

This short-acting insulin is suitable for patients requiring rapid and reliable control of postprandial glucose.

Key Benefits

• Rapid onset of action helps control blood sugar spikes after meals

• Short duration of action allows flexible dose adjustments for different meals and daily schedules

• Recombinant DNA technology ensures high purity and reduced risk of immune reactions compared to animal insulin

• Predictable pharmacokinetics provide reliable and consistent glucose control

• Compatible with subcutaneous injections or insulin pumps for precise delivery

Mysulin R Injection 40 IU/ml helps patients maintain optimal glycemic levels, reducing the risk of long-term diabetes complications such as cardiovascular disease, neuropathy, and retinopathy.

Dosage and Administration

• The dosage of Mysulin R Injection 40 IU/ml must be individualized according to the patient’s blood glucose levels, dietary intake, and physical activity.

• Administer subcutaneously in the abdomen, thigh, or upper arm 15–30 minutes before meals.

• It can also be administered intravenously in a hospital setting under medical supervision, for rapid glucose control in emergencies.

• Rotate injection sites to prevent lipodystrophy and ensure consistent absorption.

• Regular blood glucose monitoring is essential to adjust the dose and prevent hypo- or hyperglycemia.

Precautions

• Monitor for hypoglycemia and be aware of early symptoms such as sweating, shakiness, dizziness, and palpitations.

• Adjust dosage during illness, increased physical activity, dietary changes, or stress.

• Inform your healthcare provider of all medications to prevent interactions affecting blood glucose.

• Pregnant or breastfeeding women should use this insulin under medical supervision.

• Keep a fast-acting sugar source available for emergency management of low blood sugar.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Mysulin R Injection 40 IU/ml is generally well tolerated, though possible side effects include:

• Hypoglycemia (low blood sugar)

• Injection site reactions, including redness, swelling, or mild pain

• Weight gain with long-term therapy

• Rare allergic reactions, such as rash, itching, or anaphylaxis

Most side effects are manageable with dose adjustment and regular monitoring.

Storage Instructions

• Store unopened vials in a refrigerator at 2–8°C. Do not freeze.

• Protect from light and moisture.

• Once opened, it may be kept at room temperature (below 30°C) for the period advised by a physician.

• Keep out of reach of children.

Mysulin R Injection 40 IU/ml (Insulin Human [rDNA]) provides rapid, predictable glucose control for patients with type 1 and type 2 diabetes, helping maintain stable blood sugar levels and supporting effective long-term diabetes management.